16.80
Tectonic Therapeutic Inc stock is traded at $16.80, with a volume of 683.46K.
It is down -2.72% in the last 24 hours and down -25.43% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$17.27
Open:
$17.3
24h Volume:
683.46K
Relative Volume:
2.39
Market Cap:
$314.36M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-34.22%
1M Performance:
-25.43%
6M Performance:
-29.88%
1Y Performance:
-8.05%
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TECX
Tectonic Therapeutic Inc
|
16.80 | 323.16M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-03-25 | Initiated | Oppenheimer | Outperform |
Jul-21-25 | Initiated | Truist | Buy |
Jun-11-25 | Resumed | Raymond James | Outperform |
Apr-21-25 | Initiated | Mizuho | Outperform |
Nov-20-24 | Initiated | Raymond James | Outperform |
Aug-22-24 | Initiated | Wells Fargo | Overweight |
Jun-26-24 | Initiated | Piper Sandler | Overweight |
Jun-24-24 | Initiated | TD Cowen | Buy |
Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jun-15-21 | Initiated | BTIG Research | Buy |
May-27-21 | Initiated | Needham | Buy |
Mar-09-21 | Initiated | Barclays | Overweight |
Mar-02-21 | Initiated | Stifel | Hold |
Nov-11-20 | Initiated | Berenberg | Buy |
Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
Jun-27-19 | Initiated | Mizuho | Buy |
Apr-05-19 | Initiated | Janney | Buy |
Oct-10-18 | Initiated | Guggenheim | Buy |
Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
Sep-17-18 | Initiated | H.C. Wainwright | Buy |
Jul-16-18 | Initiated | Wedbush | Outperform |
Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Should you hold or exit Tectonic Therapeutic Inc. nowMarket Growth Report & Comprehensive Market Scan Reports - Newser
Why Tectonic Therapeutic Inc. is moving todayMarket Performance Report & High Accuracy Investment Signals - Newser
Can Tectonic Therapeutic Inc. recover in the next quarterBear Alert & Low Drawdown Momentum Trade Ideas - Newser
Tectonic Therapeutic Inc.’s volatility index tracking explained2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser
Using Python tools to backtest Tectonic Therapeutic Inc. strategiesTrade Analysis Report & Verified Swing Trading Watchlists - Newser
Can Tectonic Therapeutic Inc. stock outperform in a bear marketEarnings Trend Report & Low Risk High Reward Ideas - خودرو بانک
Institutional scanner results for Tectonic Therapeutic Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser
Tectonic pullback on Eli Lilly relaxin data ‘overdone,’ says Truist - MSN
Technical signs of recovery in Tectonic Therapeutic Inc.Portfolio Value Summary & Long-Term Growth Plans - Newser
Top chart patterns to watch in Tectonic Therapeutic Inc.July 2025 Patterns & AI Forecast Swing Trade Picks - Newser
Oppenheimer Holdings Inc. shares rise 2.11% premarket after initiating coverage on KB Home and Tectonic Therapeutic. - AInvest
Does Tectonic Therapeutic Inc. show high probability of reboundInsider Selling & Short-Term Swing Trade Alerts - Newser
Historical volatility pattern of Tectonic Therapeutic Inc. visualizedSell Signal & Expert Approved Trade Ideas - Newser
Can Tectonic Therapeutic Inc. stock double in the next yearMarket Performance Summary & Weekly Stock Breakout Alerts - خودرو بانک
Tectonic Therapeutic Initiates Coverage with Outperform Rating at Oppenheimer, Sets Price Target at $80 - AInvest
Tectonic Therapeutic a new outperform at Oppenheimer on heart drug asset - Seeking Alpha
Insiders Re-Evaluate Their US$62.6m Stock Purchase As Tectonic Therapeutic Falls To US$478m - 富途牛牛
Tectonic Stock Soars Pre-market After Tuesday’s Sell-Off: Oppenheimer Is Hopeful About Company’s Lead Candidate - Asianet Newsable
How to build a dashboard for Tectonic Therapeutic Inc. stockQuarterly Portfolio Review & AI Driven Price Predictions - Newser
Oppenheimer initiates Tectonic Therapeutics stock with Outperform rating - Investing.com
Tectonic Therapeutic shares rise 2.28% premarket after Oppenheimer initiates coverage with an Outperform rating. - AInvest
Tectonic Therapeutic initiated with an Outperform at Oppenheimer - TipRanks
Oppenheimer Initiates Tectonic Therapeutic at Outperform With $80 Price Target - MarketScreener
Insider Purchases Worth US$62.6m See Losses As Tectonic Therapeutic Market Value Drops To US$478m - simplywall.st
Detecting price anomalies in Tectonic Therapeutic Inc. with AIEarnings Recap Report & AI Driven Stock Price Forecasts - Newser
Visualizing Tectonic Therapeutic Inc. stock with heatmaps2025 Institutional Moves & Weekly Watchlist for Hot Stocks - Newser
Visual analytics tools that track Tectonic Therapeutic Inc. performanceMarket Activity Recap & Precise Entry and Exit Recommendations - Newser
Will Tectonic Therapeutic Inc. bounce back from current support2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser
Confidence in Tectonic Therapeutic’s Strategic Approach Amid Eli Lilly’s Trial Setback - TipRanks
Custom strategy builders for tracking Tectonic Therapeutic Inc.Market Performance Recap & Consistent Profit Alerts - Newser
Tectonic Therapeutic shares fall 31.75% intraday after reporting Q2 2025 earnings and industry-wide layoffs. - AInvest
Will Tectonic Therapeutic Inc. benefit from rate cutsTrade Analysis Report & Consistent Profit Trading Strategies - خودرو بانک
Wellington Management Group LLP Invests $348,000 in Tectonic Therapeutic, Inc. $TECX - Defense World
Short interest data insights for Tectonic Therapeutic Inc.Portfolio Return Summary & Risk Controlled Stock Pick Alerts - Newser
Backtesting results for Tectonic Therapeutic Inc. trading strategies2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Is now a turning point for Tectonic Therapeutic Inc.Earnings Summary Report & Accurate Entry/Exit Alerts - Newser
Using data models to predict Tectonic Therapeutic Inc. stock movementMarket Weekly Review & Momentum Based Trading Ideas - Newser
Can Tectonic Therapeutic Inc. be the next market leaderMarket Sentiment Review & Capital Efficient Trading Techniques - خودرو بانک
What is the dividend yield of Tectonic Therapeutic Inc.Quarterly Earnings Report & Free Community Consensus Stock Picks - خودرو بانک
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Tectonic Therapeutic Inc Stock (TECX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
45,858 |
767,204 |
1,449,652 |
SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
21,071 |
311,020 |
1,403,794 |
SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
16.31 |
9,478 |
154,586 |
4,334,846 |
SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
8,092 |
135,379 |
4,325,368 |
SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
3,718 |
54,880 |
4,317,276 |
SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
412,500 |
7,053,750 |
1,382,723 |
SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
87,500 |
1,496,250 |
4,313,558 |
MCGUIRE TERRANCE | Director |
Apr 07 '25 |
Sale |
17.10 |
500,000 |
8,550,000 |
573,062 |
SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
50.00 |
660,000 |
33,000,000 |
970,223 |
SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
54.14 |
129,294 |
6,999,977 |
4,226,058 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):